SNMMI calls for broader coverage of amyloid PET imaging

07/9/2013 | (free registration)

SNMMI said it is disappointed with a recent CMS draft decision to restrict coverage of beta-amyloid PET imaging to one scan per patient. In addition, the scan must be part of a clinical trial under a coverage-with-evidence development program. The group argues that data support broader coverage of the scan and that testing improves patient management. SNMMI is developing an education program for doctors regarding referral for and interpretation of the test.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA